RAPID Pathway Aims to Fast-Track Medicare Coverage for Breakthrough Devices
TL;DR Summary
CMS and FDA unveiled the RAPID coverage pathway to align FDA market authorization with Medicare national coverage decisions for eligible Breakthrough Devices (Class II and III). The program enables early, coordinated engagement with manufacturers, uses the FDA's market authorization to trigger a proposed NCD the same day, includes a 30‑day public comment period, and aims for coverage as soon as two months after FDA approval. The Transitional Coverage for Emerging Technologies (TCET) pathway will be paused to focus on RAPID, and a procedural notice will be published in the Federal Register for public input.
Topics:business#breakthrough-devices#fda#health-policy#medicare#rapid-coverage-pathway#regulatory-alignment
- CMS and FDA Announce RAPID Coverage Pathway to Accelerate Patient Access to Life-Changing Medical Devices Centers for Medicare & Medicaid Services | CMS (.gov)
- US to speed up payments for new medical devices Financial Times
- US to Speed Insurance Coverage for Breakthrough Medical Devices Bloomberg.com
- US Health Regulators to Speed up Medicare Device Coverage U.S. News & World Report
- CMS proposes repeal of add-on payment path for breakthrough devices MedTech Dive
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
3 min
vs 4 min read
Condensed
88%
777 → 94 words
Want the full story? Read the original article
Read on Centers for Medicare & Medicaid Services | CMS (.gov)